Express Diagnostics thanks distributors, staff, and community in celebrating its 10th anniversary
Blue Earth, Minn. (PRWEB) October 01, 2014 -- Express Diagnostics Int’l, Inc., FDA-registered manufacturer of DrugCheck® onsite drugs of abuse screening devices, today announced upcoming 10th anniversary celebrations of the company’s founding. Anniversary celebrations will include a lunch and commemorative gifts for employees, as well as an open house October 28, from 3 to 6 p.m. The public is invited to the open house at the Express Diagnostics headquarters at 1550 Industrial Drive to tour the facility, meet staff, and enjoy refreshments.
Express Diagnostics was founded on October 4, 2004, by CEO Paul Johnson, COO Rich Strasser, and three additional partners. As distributors of DrugCheck onsite screening devices through their respective companies, the founders recognized the opportunities available with the purchase of the DrugCheck brand, which was completed at the inception of the company.
From its founding with one full-time employee, Express Diagnostics has grown to employ over 100 people, manufacturing product for distribution partners in over 60 countries, including distributors with exclusivity in Australia and Mexico. EDI also has company representatives in California, Colorado, Massachusetts, and Strasbourg, France.
The production processes employed by Express Diagnostics are some of the most advanced in the industry and, coupled with continual product innovation and skilled staff, provide customers 100% U.S.-made, cost-effective alternatives to devices manufactured in traditionally low-labor-cost countries.
“The company’s success can be attributed primarily to our distributor partners, dedicated staff, and a supportive community,” says Johnson. “Express Diagnostics has grown significantly in the decade since its founding thanks to our discerning customers and staff, and the support of Blue Earth area residents and businesses. Our continued success is directly tied to the efforts of these folks and we thank them.”
In its 10 years of operation, EDI has been a consistent leader in drugs of abuse and alcohol testing with first-to-market urine tests for alcohol, K2/Spice, gamma-hydroxybutyric acid (GHB), and Ethyl Glucuronide (EtG), a unique biomarker of alcohol use. Express Diagnostics has also been named to the Inc. 5000 list of fastest-growing companies in the U.S. the last two years in a row.
About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® on-site urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of rapid alcohol screening and health diagnostics devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. The company also provides complete OEM and private-label design and manufacturing at its FDA-registered, ISO 13485:2003-certified facility in Blue Earth, Minn. Learn more at drugcheck.com.
Beth Moss, Express Diagnostics Int'l, Inc., http://www.drugcheck.com, 507-526-3951 Ext: 4870, [email protected]
Share this article